Introduction
Atrial fibrillation is a common supra-ventricular arrhythmia with an estimated prevalence of 1.5 to 2% among the general population in the developed world, with the peak incidence occurring between 75 and 85 years of age. It is well recognised to be associated with a five-fold increased risk of stroke and a three-fold increased risk of congestive heart failure, with an overall increased mortality. 1, 2 Diagnosing atrial fibrillation before complications arise is a clinical priority, especially in patients who are more than 65 years of age using, for example, opportunistic screening by pulse palpation, followed by ECG monitoring in those with irregular pulses. [3] [4] [5] By definition, atrial fibrillation is the result of abnormal chaotic contractions of the atrium documented by ECG monitoring, with a duration of at least 30 seconds or, if less than 30 seconds, present continuously throughout the ECG tracing. A rhythm strip on an ECG is essential for diagnosis, showing irregular R-R intervals in the absence of complete atrio-ventricular block or distinct P waves and a variable atrial cycle, which is less than 200 ms when visible on ECG. As it is known to be associated with a trigger or an arrythmogenic substrate, atrial fibrillation ablation procedures work by eliminating the triggers or altering the arrythmogenic substrates of atrial fibrillation. 5 Pulmonary veins have been identified as the most common, but not the only, site to trigger atrial fibrillation. Ectopic beats abruptly transform into a sudden burst of rapid discharges which lead to pathological complications; this cycle of events can be prevented by ablation of the focal trigger as demonstrated by Haissaguerre et al in their landmark observational study. 6 It has now been recognised that myocardial muscle fibres which extend from the left atrium into the pulmonary veins are important sources of focal firing that trigger and maintain atrial fibrillation. 2 The success of the Maze III procedure in the early 1990s, which was designed to eliminate or block all possible anatomical re-entrant circuits in both atria, has led to the development and evolution of ablation techniques. Currently, the most commonly employed ablation strategy is electrical isolation targeting the pulmonary veins and/or pulmonary vein antrum; this remains the cornerstone for most atrial fibrillation ablation procedures. 5 Radiofrequency catheter ablation (RFA) has emerged to be an effective and potential curative treatment for recurrent, drug-refractory atrial fibrillation. 7, 8 Over the years, various methods have been discovered including extensive circumferential pulmonary vein isolation [9] [10] [11] [12] and linear ablation. [13] [14] [15] [16] Despite the efficacy of this technique, it has been linked with more severe complication risks, such as vascular access accidents, cardiac perforation or tamponade, thromboembolic events, pulmonary valve stenosis and extra-cardiac injuries. The incidence of complications 5 after RFA ranges from 1.4% to 6%. We present the case of a patient who suffered and ultimately died from one such complication.
Case presentation
A 46-year-old Caucasian male presented to hospital with recurrent episodes of chest pain, jaw tightness, dyspnoea and palpitations, and was subsequently found on ECG to be in rapid atrial fibrillation. He had a significant cardiac history including repair of co-arctation of aorta in 1989 and pericardial stripping for constrictive pericarditis in 2006. Initial echocardiography showed left-sided heart failure with severe systolic dysfunction and an ejection fraction of 30%, a bicuspid aortic valve with horizontal orientation and aortic regurgitation, and surgical remodelling of the aortic arch. His Fatal atrial oesophageal fistula following pulmonary vein isolation: an unresolved safety issue 3C00
S Y Loo, K Sundararajan
Atrial fibrillation is a common cardiac arrhythmia that is associated with high morbidity and mortality. Radiofrequency ablation with extensive circumferential pulmonary vein isolation has been recognised as the most commonly employed ablation method to treat recurrent atrial fibrillation that is refractory to drug therapy. Atrial-oesophageal fistula is one of the most devastating complications following this procedure and has implications for intensive care clinicians. We report the clinical course of a patient with an extensive history of recurrent, drug-refractory atrial fibrillation who developed atrial-oesophageal fistula three weeks after pulmonary vein isolation, suffered a series of complications as a consequence, and eventually died.
Keywords: atrial fibrillation; radiofrequency ablation; pulmonary vein isolation; complications; atrial oesophageal fistula
chronic condition was poorly controlled with medical management, resulting in relapses of his symptoms and multiple admissions due to similar problems.
As a result of his ongoing drug-refractory atrial fibrillation, he underwent pulmonary vein isolation. After the procedure he developed acute urinary retention requiring catheterisation, which was subsequently complicated by acute kidney injury, fluid overload, and a lower respiratory tract infection; these were managed by prompt re-catheterisation, furosemide and oral antibiotics. A routine post-procedure echocardiogram showed no evidence of residual complications and he was discharged home.
Three weeks after the procedure, he re-presented to the hospital with chills, fever, rigors and collapse with loss of consciousness in the emergency department. On examination, he was found to be tachycardic, hypotensive (blood pressure of 90/60 mm Hg), febrile (temperature of 39°C), with an altered mental state, and right upper quadrant pain on palpation. Repeat echocardiogram revealed new antero-septal and anterior wall akinesia, poor visualisation of the aortic arch and descending aorta and an ejection fraction of 40%. An urgent computerised tomography (CT) angiogram of the chest was performed in light of the clinical signs of septic shock in order to rule out post-pulmonary vein isolation atrial-oesophageal fistula or aortic dissection. The scan showed evidence of mediastinitis and locules of gas outside the oesophagus and behind the atrium, suggestive of possible atrial-oesophageal fistula (Figure 1) .
The patient was immediately transferred to the intensive care unit (ICU) for multisystem organ support. Empirical antibiotic treatment was started, as he was too unwell for surgery. Overnight, he developed a dense right hemiparesis and global aphasia; an urgent CT of his brain showed a left middle cerebral artery stroke (Figure 2 ), presumed to be of cardioembolic or septic origin. His condition worsened, and he developed haematemesis, which prevented the use of thrombolysis for immediate management of the stroke. An oesophageal stent was inserted as a temporary measure to control active bleeding from the atrial-oesophageal fistula.
He was subsequently managed on the stroke unit. He was noted to have ongoing atrial fibrillation and warfarin therapy was started to prevent further embolic complications. Unfortunately, warfarin therapy was associated with multiple episodes of recurrent haematemesis and maelena and immediate cessation was required. Despite stopping the warfarin, he continued to deteriorate and developed hypovolemic shock. He was re-admitted to ICU for ventilatory and circulatory support after repeated episodes of haematemesis and for treatment of sepsis and mediastinitis. Antimicrobial treatment specifically targeted sepsis due to vancomyin-resistant Enterococcus, meticillin-resistant Staphylococcus aureus, and Candida albicans.
After two months in ICU, and in view of the short-term management of the atrial-oesophageal fistula, a second stent insertion was attempted endoscopically, but was unsuccessful. A week later the patient had improved to the point where he was able to return to the ward for possible rehabilitation; however, his stroke symptoms included global aphasia and inability to follow commands that made rehabilitation very difficult.
He developed another episode of severe sepsis shortly after returning to the ward. Considering the poor prognosis and gradual worsening of his condition, his family accepted the medical recommendation not to escalate treatment further and to change his management focus towards palliative care. All active treatment was withdrawn and the palliative care team managed the patient in the days leading up to his death.
Discussion
This case draws attention to a rare but devastating, lethal extracardiac complication of pulmonary vein isolation treatment for atrial fibrillation. Oesophageal complications (mainly atrialoesophageal fistula) are very rare, with rates of 0.01-0.2% and 1-1.5% following percutaneous and surgical ablation respectively. 5, 17 When an atrial-oesophageal fistula does occur, it results from extra-cardiac penetration of the ablative energy, and is one of the most devastating and lethal extra-cardiac complications of the procedure. 7 The complication was first described in the surgical literature in 2001 18 and in the medical literature in 2004. 5 It occurs ostensibly due to perforation into the pericardial space, with an incidence ranging from 0.6 to 1.3%. 7, 8, [19] [20] [21] It is currently the second most common cause of death (after cardiac tamponade) following pulmonary vein isolation, with a mortality rate of 70%. 19, 20 Patients suffering from atrial-oesophageal fistula usually present with nonspecific symptoms including fever, dysphagia, chest pain and seizure, which begin 3 to 35 days after pulmonary vein isolation. Some patients may present with Developing left MCA territory ischaemia with focal infarct Case reports endocarditis, pericarditis and subsequently embolism, further complicated by myocardial or cerebral infarction. 7 Thoracic CT with oral or intravenous contrast enhancement is the most useful investigation, with highly specific findings. 5, 7 Transthoracic echocardiography is less useful due to its lack of specificity. Trans-oesophageal echocardiography should be avoided as it could potentially lead to rapid deterioration and death. Gastro-oesophageal endoscopy is contraindicated due to the requirement for gas insufflation that could result in massive haemorrhage as a result of air embolism and/or barotrauma. 5, 7, 19 The development of late atrial-oesophageal fistula, as in our patient, is associated with a very high morbidity and mortality rate of more than 80%. Those who survive such complications are often left with disability from cerebrovascular events. 5 The oesophagus is particularly at risk of injury following pulmonary vein isolation. Two studies previously revealed the close contact between the oesophagus and posterior left atrium, using a 16-row multi-detector CT scanner in patients with atrial fibrillation; they also showed the non-uniform thickness of the posterior left atrium and variable fibro-fatty layer between the atrial wall and oesophagus. These findings suggest that the oesophagus is prone to heat damage following RFA applied to the posterior left atrium. 7, 22, 23 Clinicians have difficulty in making the diagnosis of atrialoesophageal fistula due to its nonspecific symptoms and late development after the procedure. This lack of early recognition prevents prompt treatment. 7, 24 Several measures around the time of the procedure may help prevent the complication; these include: monitoring oesophageal temperature, 25 exploration of the anatomical relationship [26] [27] [28] between oesophagus and left atrium using various imaging modalities, reducing radiofrequency power during posterior left atrium ablation, oesophageal cooling with a cooled water-irrigated intraoesophageal balloon, 29 conducting the procedure under conscious sedation 30 to assess pain, which can be used as a surrogate marker for oesophageal injury, and patient education in recognising the warning signs (including fever, dysphagia and chest discomfort within three days to five weeks after the procedure). 24, 25 To reduce the risk of this complication it has been suggested that, prior to the procedure, mapping using CT angiography after a barium swallow, or magnetic resonance contrast angiography with swallowed barium sulphate paste, gadolinium glutamate or electro-anatomical mapping should be used. Treatment with a combination of proton-pump inhibitors and H 2 antagonists has been applied to reduce the risk of oesophageal ulceration post-radiofrequency ablation, but not to decrease the incidence of atrial-oesophageal fistula. 9 In cases where there is early recognition of the symptoms of atrial-oesophageal fistula, surgical intervention with appropriate antimicrobial therapy if the patient is haemodynamically unstable 24, 30 should be undertaken. Due to the complexity of this patient' s condition, prevention of this devastating complication would have been a better option. Pappone 19, 28 et al suggested lowering radiofrequency power to 50 W and maintaining oesophageal temperature at 55°C during posterior left atrium ablation, to avoid excessively deep extra-cardiac penetration of ablation energy and subsequent oesophageal injury. Another suggestion is to use a transverse posterior line 7 at the roof during the procedure, as the atrium tends to be thicker here and is not in direct contact with the oesophagus. Kuwahara 25 et al demonstrated the use of a fluoroscopic-guided deflectable temperature probe, with no atrial-oesophageal fistula following radiofrequency ablation. Radiofrequency energy delivery applied at 35 W was ceased when oesophageal temperature reached 42°C and resumed at the same location when oesophageal temperature dropped to less than 38°C. 25 If preventative measures fail and the patient does sustain an atrial-oesophageal fistula, the prognosis is guarded. Currently, there are few reports of survival after emergency cardiac and oesophageal surgery. 15, 16 Shim 15 and colleagues reported a case of successful management of atrial-oesophageal fistula following circumferential ablation of the pulmonary vein antra with a maximum pre-set power averaging 30-35 W; the patient survived an emergency surgical repair. Bunch 16 et al reported the first case of successful temporary stenting for oesophageal perforation following ablation, making it a promising treatment option in cases where an early diagnosis of the perforation is made by the clinician.
There has been a trend to map the electro-physiologic substrate, and research is currently under way to try and identify localised sources maintaining atrial fibrillation organised by prior ablation. These could be considered potential areas for future research. 31, 32 Prevention is of the essence, and unless significant progress is made in the area of stent repair for oesophageal perforation, atrial-oesophageal fistula will continue to remain a devastating complication after pulmonary vein isolation, associated with high morbidity and mortality. 7
Conclusion
Atrial-oesophageal fistula remains an unresolved safety issue post-pulmonary vein isolation even though the outcomes following an uncomplicated procedure are good in experienced hands. Given that interventional cardiologists use this modality as a curative treatment for drug-refractory atrial fibrillation, it is crucial for intensive care doctors to be aware of this lethal complication as more and more centres deploy this therapy for atrial fibrillation. As clinicians continue to gain more experience, properly designed clinical studies should be undertaken to identify the ideal radiofrequency energy delivery and oesophageal temperature during catheter ablation to minimise the incidence of atrial-oesophageal fistula.
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